The inhibitors, FAK inhibitor Y15 (110), Monastraol and Ispinesib have been found to target KIF11 in GBM, and KIF11 inhibition has been shown to prolonged the survival of mice bearing orthotropic GBM (109). The gene discussed is PTK2; the disease is glioblastoma.